Andrew Patterson, PhD, MBA

We are Leading AI powered Drug Development and Precision Medicine Smart Imaging Strategy to Accelerate Drug Development Cloud Platform DYNAMIKA for Central Data Management and Review Superior Science and Risk-Sharing Business Models
1636132351148_out2

Andrew Patterson, PhD, MBA

Director of Scientific and Medical Affairs
Dr Patterson has experience in selecting optimal imaging and AI strategies to accelerate drug development. Andrew is an active researcher with over 70 papers focusing on the development of novel imaging biomarkers.